Comparison of Biologics and Oral Treatments for Plaque Psoriasis
April W. Armstrong(University of Southern California), Matthias Augustin(University Medical Center Hamburg-Eppendorf)
Cited by 278
Related Papers
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
|Journal of the American Academy of Dermatology|2019|917
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities
|Journal of the American Academy of Dermatology|2019|484
Deucravacitinib: A Novel TYK2 Inhibitor for the Treatment of Moderate-to-Severe Psoriasis
|Journal of Psoriasis and Psoriatic Arthritis|2023|25
Shared decision-making and satisfaction with care in patients with psoriasis: A population-based study in the United States
|Journal of the American Academy of Dermatology|2023|19
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
|Journal of the American Academy of Dermatology|2024|19